CSPC PHARMACEUT.GR. ADR4 (CVGU) — Cash Flow Reinvestment Rate
CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Cash Flow Reinvestment Rate of 0.74x as of December 2025, reinvesting €4.33 Billion (capex €2.28 Billion plus investments €-2.05 Billion) from operating cash flow of €5.83 Billion. Explore reinvestment intensity of CSPC PHARMACEUT.GR. ADR4 to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
CSPC PHARMACEUT.GR. ADR4 Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for CSPC PHARMACEUT.GR. ADR4 across 5 annual periods. Also explore CSPC PHARMACEUT.GR. ADR4 balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for CSPC PHARMACEUT.GR. ADR4 (2021–2025)
Year-by-year capital reinvestment analysis for CSPC PHARMACEUT.GR. ADR4. For live market cap and broader valuation context, see CSPC PHARMACEUT.GR. ADR4 (CVGU) total market value.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.74x | €4.33 Billion | €5.83 Billion | €2.28 Billion | ▼ -18.3% |
| 2024 | 0.91x | €4.12 Billion | €4.53 Billion | €2.68 Billion | ▼ -9.1% |
| 2023 | 1.00x | €4.18 Billion | €4.18 Billion | €1.89 Billion | ▲ +15.8% |
| 2022 | 0.86x | €6.59 Billion | €7.63 Billion | €2.72 Billion | ▲ +114.8% |
| 2021 | 0.40x | €1.86 Billion | €4.64 Billion | €1.76 Billion | — |